Report |
From the Hubrecht Institute (R.H., S.S.-M.), Utrecht; and Molecular Cardiology Laboratory (R.H., E.v.d.K., H.J.D.), Experimental Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands.
Correspondence to Stefan Schulte-Merker, Hubrecht Institute, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands. E-mail s.schulte{at}niob.knaw.nl
| Abstract |
|---|
|
|
|---|
Key Words: zebrafish sox7 sox18 AV-differentiation hypotrichosis–lymphedema–telangiectasia hereditary hemorrhagic telangiectasia
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Histological Procedures
In situ hybridization and immuno-histochemistry were performed as described.5,13 The riboprobes used are specified in the online data supplement, available at http://circres.ahajournals.org.
Morpholino Injections and Microangiographs
Procedures are specified in the online data supplement.
| Results and Discussion |
|---|
|
|
|---|
|
Morpholino Knockdown Analysis of sox7 and sox18
Embryos injected with morpholinos (MOs) targeting sox7 or sox18 individually (two independent MOs for each gene; see supplemental Figure III for specificity tests) did not show any apparent morphological defects, or loss of endothelial cells (supplemental Figure I), or loss of circulation (supplementary Movies 2 to 3). Strikingly, on simultaneous injection of low amounts of both sox7- and sox18-MO, virtually all double knockdowns (dKDs) exhibited a loss of circulation in the posterior part of the embryo, whereas cardiac contractile function was normal (Figure 1E; supplementary Movie 1). Later, blood accumulated in a short circulatory loop near the heart leading to pericardial edema (>2 days post fertilization; not shown). Endothelial cells were specified in sox7/sox18-dKDs as demonstrated by fli1a:gfp expression, but we noticed poor segregation of artery and vein (compare supplemental Figure Ij and Im, insets). In addition, in microangiographs, the major axial vessels in the posterior part of sox7/sox18-dKDs were not filled with dye at 2 days postfertilization (Figure 1C and 1D). Dye injected into the sinus venosus drained from the heart into the posterior cardinal vein (PCV) rather than the dorsal aorta (DA) (Figure 1D, arrow). We conclude that combined loss of sox7 and sox18 function results in a severe disturbance of circulation.
Arteriovenous Specification and Vascular Tube Formation in sox7/sox18-dKDs
To further investigate this phenotype, we analyzed the expression of several molecular markers in sox7/sox18-dKDs compared with uninjected control embryos or silent heart morphants.15 No alteration was detectable in the primitive erythroid lineage marker gata1 (supplemental Figure IV), vegf receptors 2 and 4, or pan-endothelial markers like tie2, cdh5, and fli1a (not shown). However, we observed a dramatic decrease in the expression of arterial markers notch3, ephrinB2a (Figure 2A through 2D), and dll4 (supplemental Figure IV) and a concurrent increase in the expression of venous markers dab2 and flt4 in arterial tissues, such as the DA and intersegmental vessels (supplemental Figure IV and Figure 2C and 2F, respectively). These results suggest a key role for sox7 and sox18 in specifying the arterial fate of endothelial cells. A possible shift in AV identity attributable to the lack of circulation was excluded by analyzing silent heart morphants, which showed no alteration in marker gene expression (Figure 2C and supplemental Figure VI). This demonstrates that sox7 and sox18 are essential regulators of AV identity.
|
To better understand the lack of lumen formation observed in sox7/sox18-dKDs in microangiographs, we next examined transverse sections of sox7/sox18-dKDs, uninjected control embryos, and silent heart morphants. The nonvascular morphology in sox7/sox18-dKDs (Figure 3C) was completely normal, suggesting a vessel-specific phenotype. Uninjected controls and silent heart morphants exhibited normal segregation and lumenization of axial vessels (Figure 3A, 3B, 3D, and 3E). In all sox7/sox18-dKDs (n=16), we observed stretches of normal and physically separated axial vessels, alternating with regions where only a single PCV was present. At particular locations in sox7/sox18-dKDs, the DA apparently fused with the PCV (Figure 3C and 3F; see also supplemental Figure V). We conclude that the combined loss of Sox7 and Sox18 function disrupts AV specification and leads to severe shunt formation.
|
Our study provides novel insights into the molecular roles of sox7 and sox18, which are essential to the specification of the molecular identity of the dorsal aorta during embryogenesis and possibly during later stages of life. These findings, for the first time, offer direct insights into the molecular consequences of Sox function in endothelial cells at the in vivo level. Understanding the requirement for Sox7 and Sox18 in the process of arteriovenous specification might help to better understand syndromes such as hypotrichosis–lymphedema–telangiectasia and hereditary hemorrhagic telangiectasia.
| Acknowledgments |
|---|
Sources of Funding
This work was supported by a VIDI grant (H.J.D.) and the Royal Netherlands Academy of Arts and Sciences (S.S.-M.).
Disclosures
None.
| Footnotes |
|---|
Original received August 30, 2007; resubmission received October 15, 2007; revised resubmission received November 8, 2007; accepted November 14, 2007.
| References |
|---|
|
|
|---|
2. Sorensen LK, Brooke BS, Li DY, Urness LD. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev Biol. 2003; 261: 235–250.[CrossRef][Medline] [Order article via Infotrieve]
3. Urness LD, Sorensen LK, Li DY. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet. 2000; 26: 328–331.[CrossRef][Medline] [Order article via Infotrieve]
4. Lawson ND, Vogel AM, Weinstein BM. Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell. 2002; 3: 127–136.[CrossRef][Medline] [Order article via Infotrieve]
5. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development. 2005; 132: 5199–5209.
6. Liang D, Chang JR, Chin AJ, Smith A, Kelly C, Weinberg ES, Ge R. The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech Dev. 2001; 108: 29–43.[CrossRef][Medline] [Order article via Infotrieve]
7. Fouquet B, Weinstein BM, Serluca FC, Fishman MC. Vessel patterning in the embryo of the zebrafish: guidance by notochord. Dev Biol. 1997; 183: 37–48.[CrossRef][Medline] [Order article via Infotrieve]
8. Sumanas S, Lin S. Ets1-related protein is a key regulator of vasculogenesis in zebrafish. PLoS Biol. 2006; 4: e10.[CrossRef][Medline] [Order article via Infotrieve]
9. Bowles J, Schepers G, Koopman P. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol. 2000; 227: 239–255.[CrossRef][Medline] [Order article via Infotrieve]
10. Kanai-Azuma M, Kanai Y, Gad JM, Tajima Y, Taya C, Kurohmaru M, Sanai Y, Yonekawa H, Yazaki K, Tam PP, Hayashi Y. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development. 2002; 129: 2367–2379.[Medline] [Order article via Infotrieve]
11. Kim I, Saunders TL, Morrison SJ. Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells. Cell. 2007; 130: 470–483.[CrossRef][Medline] [Order article via Infotrieve]
12. Pennisi D, Gardner J, Chambers D, Hosking B, Peters J, Muscat G, Abbott C, Koopman P. Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice. Nat Genet. 2000; 24: 434–437.[CrossRef][Medline] [Order article via Infotrieve]
13. Bussmann J, Bakkers J, Schulte-Merker S. Early endocardial morphogenesis requires Scl/Tal1. PLoS Genet. 2007; 3: e140.[CrossRef][Medline] [Order article via Infotrieve]
14. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002; 248: 307–318.[CrossRef][Medline] [Order article via Infotrieve]
15. Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, Stainier DY. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet. 2002; 31: 106–110.[CrossRef][Medline] [Order article via Infotrieve]
Related Article:
Circ. Res. 2008 102: 1-2.
This article has been cited by other articles:
![]() |
M. Downes, M. Francois, C. Ferguson, R. G. Parton, and P. Koopman Vascular defects in a mouse model of hypotrichosis-lymphedema-telangiectasia syndrome indicate a role for SOX18 in blood vessel maturation Hum. Mol. Genet., August 1, 2009; 18(15): 2839 - 2850. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hosking, M. Francois, D. Wilhelm, F. Orsenigo, A. Caprini, T. Svingen, D. Tutt, T. Davidson, C. Browne, E. Dejana, et al. Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice Development, July 15, 2009; 136(14): 2385 - 2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Savage, A. J. Conley, A. Blais, and I. S. Skerjanc SOX15 and SOX7 Differentially Regulate the Myogenic Program in P19 Cells Stem Cells, June 1, 2009; 27(6): 1231 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Limaye, L. M. Boon, and M. Vikkula From germline towards somatic mutations in the pathophysiology of vascular anomalies Hum. Mol. Genet., April 15, 2009; 18(R1): R65 - R74. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Swift and B. M. Weinstein Arterial-Venous Specification During Development Circ. Res., March 13, 2009; 104(5): 576 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aitsebaomo, A. L. Portbury, J. C. Schisler, and C. Patterson Brothers and Sisters: Molecular Insights Into Arterial-Venous Heterogeneity Circ. Res., October 24, 2008; 103(9): 929 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Jin and C. Patterson Partners in Crime: How Two Sox Proteins Cooperate to Specify Arterial Fate Circ. Res., January 4, 2008; 102(1): 1 - 2. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |